drug combination

199 articles

Research
July 19, 2022 • 2 Min

Four-Drug Combination Tested in Metastatic Pancreatic Cancer

A clinical trial is testing a drug combination including a drug used for erectile dysfunction, a new drug, and two immunotherapy drugs.

Research
December 5, 2024 • 4 Min

Using A Virus to Reach the Tumor

Dr. Tara Seery is fascinated by the potential of an oncolytic virus to make chemotherapy more effective for pancreatic cancer.

Research
January 27, 2022 • 6 Min

A Report from ASCO GI 2022

Clinical trials were reported on at ASCO GI 2022, as well as reports on COVID, virtual tumor boards, and racial disparities in treatment.

Research
June 24, 2024 • 2 Min

More Effective Treatment for Metastatic Pancreatic Cancer

A worldwide clinical trial is testing a new drug combined with standard treatment, for patients with metastatic pancreatic cancer.

Research
August 24, 2018 • 5 Min

New Research Sheds Light on Hot and Cold Tumors

Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.

Research
November 20, 2023 • 4 Min

Two-Drug Combo Targets KRAS and Fights Resistance

Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.

Research
January 27, 2021 • 6 Min

A Look at MEK and Autophagy Inhibition

Dr. Conan Kinsey looks at the MEK pathway as way to make immunotherapy more effective for pancreatic cancer patients.

Research
April 19, 2024 • 2 Min

Using Ultrasound to Enhance the Effectiveness of Chemotherapy

A clinical trial combines ultrasound with a microbubble contrast agent to make chemotherapy more effective.

Research
May 26, 2023 • 2 Min

Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome

Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.

Research
January 10, 2020 • 2 Min

Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers

Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.

Research
June 3, 2021 • 4 Min

Disappointing Results of a Phase II Trial Using Angiogenesis Inhibitor

Dr. Tanios Bekaii-Saab reports on the disappointing results of a trial combining an angiogenesis inhibitor and mFOLFIRINOX.

Research
October 12, 2022 • 6 Min

Exercise Helps Boost Immune System and Immunotherapy Treatment

Dr. Emma Kurz is part of a research team that has found that exercise can help make immunotherapy more effective for pancreatic cancer.

Research
September 5, 2017 • 4 Min

New Cancer Stem Cell Pathway Drug May Change Standard of Care

Dr. Tanios Bekaii-Saab is testing a new drug that works on pancreatic cancer stem cells to make chemotherapy more effective.

Research
May 2, 2022 • 2 Min

A New Immunotherapy Combination for Metastatic Pancreatic Cancer

Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.

Research
April 23, 2025 • 4 Min

Phase II/III Clinical Trial Recruiting Advanced Pancreatic Cancer Patients

Dr. Shalini Makawita is a primary investigator in a phase IIb/III immunotherapy clinical trial for advanced pancreatic cancer patients.